Rob Laverty has extensive experience in the field of market access. Rob started their career at Bristol-Myers Squibb in 1993, where they served as the Executive Director of Global Market Access until 2012. Rob then joined Otsuka Pharmaceutical Companies (U.S.) as the Sr. Director of Market Access from 2012 to 2015, and later became the Vice President of Market Access until 2017. Currently, they hold the position of Vice President of Market Access at Braeburn.
Rob Laverty attended Kean University from 1984 to 1989, where they studied Management Science and earned a Bachelor of Science degree. Rob then pursued their MBA in Finance from Fairleigh Dickinson University-Florham Campus from 1995 to 1999.
Org chart
Teams
Offices
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. They are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers and society.
